Predictors of Long-term Progression in the Early Manifest Glaucoma Trial

Ophthalmology

Volumn 114, Issue 11, 2007, Pages 1965-1972

  Leske, M Cristina ^a   Heijl, Anders ^b   Hyman, Leslie ^a   Bengtsson, Boel ^b   Dong, LiMing ^a   Yang, Zhongming ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL;

ADULT; AGED; ARGON LASER; ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL CORNEAL THICKNESS; CLINICAL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORNEA; DISEASE COURSE; EARLY MANIFEST GLAUCOMA TRIAL; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PERFUSION PRESSURE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SYSTOLIC BLOOD PRESSURE; TRABECULOPLASTY; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BETAXOLOL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EYE HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TRABECULECTOMY;

EID: 34848853772     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.03.016     Document Type: Article

References (36)

1. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
2. Leske M.C., Heijl A., Hussein M., et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
3. Leske M.C., Heijl A., Hyman L., et al. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106 (1999) 2144-2153
4. Bengtsson B., Lindgren A., Heijl A., et al. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand 75 (1997) 184-188
5. Cox D. Regression models and life-tables. J R Stat Soc Ser B 34 (1972) 187-220
6. Breslow N. Covariance analysis of censored survival data. Biometrics 30 (1974) 89-99
7. Allison P.D. Survival Analysis Using SAS: A Practical Guide (1995), SAS Publishing, Cary, NC 138-154
8. Grodum K., Heijl A., and Bengtsson B. Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology 112 (2005) 386-390
9. Flammer J., Orgul S., Costa V.P., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21 (2002) 359-393
10. Gherghel D., Hosking S.L., and Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 49 (2004) 491-508
11. Harris A., Rechtman E., Siesky B., et al. The role of optic nerve blood flow in the pathogenesis of glaucoma. Ophthalmol Clin North Am 18 (2005) 345-353 v
12. Grieshaber M.C., and Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol 16 (2005) 79-83
13. Tielsch J.M., Katz J., Sommer A., et al. Hypertension, perfusion pressure, and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol 113 (1995) 216-221
14. Bonomi L., Marchini G., Marraffa M., et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 107 (2000) 1287-1293
15. Mitchell P., Lee A.J., Rochtchina E., and Wang J.J. Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study. J Glaucoma 13 (2004) 319-326
16. Dielemans I., Vingerling J.R., Algra D., et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: the Rotterdam Study. Ophthalmology 102 (1995) 54-60
17. Leske M.C., and Podgor M.J. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 118 (1983) 280-287
18. Leske M.C., Connell A.M., Wu S.Y., et al. Risk factors for open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol 113 (1995) 918-924
19. Leske M.C., Warheit-Roberts L., and Wu S.Y. Open-angle glaucoma and ocular hypertension: the Long Island Glaucoma Case-Control Study. Ophthalmic Epidemiol 3 (1996) 85-96
20. Leske M.C., Wu S.Y., Nemesure B., et al. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 120 (2002) 954-959
21. Quigley H.A., West S.K., Rodriguez J., et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 119 (2001) 1819-1826
22. Pache M., and Flammer J. A sick eye in a sick body?. Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol 51 (2006) 179-212
23. Topouzis F., Coleman A.L., Harris A., et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki Eye Study. Am J Ophthalmol 142 (2006) 60-67
24. Weinstock F.J. Ophthalmic hazards of hypotensive drugs. JAMA 224 (1973) 1039
25. Hayreh S.S., Zimmerman M.B., Podhajsky P., and Alward W.L. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117 (1994) 603-624
26. Grunwald J.E., Piltz J., Hariprasad S.M., et al. Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol 127 (1999) 516-522
27. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720 discussion 829-30
28. Brandt J.D. Corneal thickness in glaucoma screening, diagnosis, and management. Curr Opin Ophthalmol 15 (2004) 85-89
29. Medeiros F.A., Sample P.A., Zangwill L.M., et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 136 (2003) 805-813
30. Jonas J.B., Stroux A., Velten I., et al. Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci 46 (2005) 1269-1274
31. Herndon L.W., Weizer J.S., and Stinnett S.S. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 122 (2004) 17-21
32. Stewart W.C., Day D.G., Jenkins J.N., et al. Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma. J Ocul Pharmacol Ther 22 (2006) 26-33
33. Papadia M, Sofianos C, Iester M, et al. Corneal thickness and visual field damage in glaucoma patients. Eye. In press.
34. Chauhan B.C., Hutchison D.M., LeBlanc R.P., et al. Central corneal thickness and progression of the visual field and optic disc in glaucoma. Br J Ophthalmol 89 (2005) 1008-1012
35. Kim J.W., and Chen P.P. Central corneal pachymetry and visual field progression in patients with open-angle glaucoma. Ophthalmology 111 (2004) 2126-2132
36. Congdon N.G., Broman A.T., Bandeen-Roche K., et al. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol 141 (2006) 868-875